Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China-Reference-Cited by-同舟云学术

Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China

Published:2015-10-29 Issue:3 Volume:7 Page:3599-3613
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Song Bin¹²³,Cui Heyang¹²,Li Yaoping¹⁴,Cheng Caixia¹²⁵,Yang Bin¹⁴,Wang Fang¹²,Kong Pengzhou¹²,Li Hongyi¹²,Zhang Ling¹²,Jia Zhiwu¹²,Bi Yanghui¹²,Wang Jiaqian⁶,Zhou Yong⁶,Liu Jing¹⁷,Wang Juan¹²,Zhao Zhenxiang¹²,Zhang Yanyan¹⁷,Hu Xiaoling¹²,Shi Ruyi¹²,Yang Jie¹²,Liu Haiyan¹²⁸,Yan Ting¹²,Li Yike¹⁷,Xu Enwei¹²⁹,Qian Yu¹²,Xi Yanfeng⁹,Guo Shiping⁴,Chen Yunqing⁴,Wang Jinfen⁹,Li Guodong⁹,Liang Jianfang⁵,Jia Junmei³,Chen Xing¹⁰,Guo Jiansheng⁷,Wang Tong¹¹,Zhang Yanbo¹¹,Li Qingshan¹²,Wang Chuangui¹³,Cheng Xiaolong¹²,Zhan Qimin¹⁴,Cui Yongping¹²

Affiliation:

1. Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, China

2. Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, China

3. Department of Oncology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

4. Department of Tumor Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi, China

5. Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

6. BGI-Shenzhen, Shenzhen, Guangdong, China

7. Department of General Surgery, the First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

8. Department of Nuclear medicine, the First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

9. Department of Pathology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China

10. Department of Endoscopy, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China

11. Department of Statistics, Shanxi Medical University, Taiyuan, Shanxi, China

12. School of Pharmaceutical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China

13. Key Laboratory of Medical Cell Biology, College of Translational Medicine, China Medical University, Shenyang, China

14. State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FBXW7 inhibits the Progression of ESCC by directly inhibiting the Stemness of Tumor Cells;2023-01-04

2. FBXW7 as a potential prognostic biomarker for ESCC inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells;2022-09-14

3. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy;Acta Pharmaceutica Sinica B;2021-09

4. NOTCH and Esophageal Squamous Cell Carcinoma;Advances in Experimental Medicine and Biology;2020-10-09

5. Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort;Frontiers in Oncology;2020-08-20